Snapshot from Sep 14, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech product launch

Philips and Imricor launch iMR lab solution

Analysis based on 10 articles · First reported Aug 27, 2026 · Last updated Aug 27, 2026

Sentiment
30
Attention
4
Articles
10
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The launch strengthens Philips' position in image-guided therapy and expands its MRI portfolio into interventional cardiology, potentially boosting demand for its 1.5T systems. For Imricor, the commercial availability of its iMR products with a major OEM partner could accelerate adoption and revenue growth, positively impacting its stock.

Medical Devices Healthcare Technology Cardiology

On August 27, 2026, Philips and Inspire Medical Systems announced the launch of a new Interventional MR (iMR) lab solution for Philips 1.5T MRI systems. The solution combines Philips' high-performance 1.5T MRI platform with Imricor's portfolio of MR-compatible systems and consumables, enabling MR-guided cardiac interventions without compromising on field strength. The first commercially available configuration includes Philips' Cardiac MR Suite with SmartHeart AI-powered planning and Imricor's NorthStar iMR mapping system, Advantage-MR EP Recorder/Stimulator, and Vision-MR electrophysiology catheters. The solution is built on Philips' BlueSeal helium-free MRI technology and is commercially available immediately in CE-marked markets and, in some configurations, the U.S. It will be showcased at ESC Congress 2026 in Munich. This launch marks a milestone in the companies' long-standing collaboration to bring MR-guided cardiac intervention into routine clinical practice, expanding the role of cardiac MRI from diagnosis into treatment.

100 Philips launched
stock
Philips is the primary developer and marketer of the iMR lab solution, leveraging its 1.5T MRI platform and BlueSeal technology. The launch expands Philips' role in cardiac MRI from diagnosis into treatment, potentially driving sales of its MRI systems and strengthening its image-guided therapy portfolio.
Importance 100.0 Sentiment 40.0
stock
Imricor is the co-developer and provider of MR-compatible interventional systems and consumables. The commercial launch of its iMR products with Philips is a significant milestone, potentially accelerating adoption and revenue growth, and validating its technology in the market.
Importance 100.0 Sentiment 60.0
per
Ioannis Panagiotelis, Business Leader for Magnetic Resonance at Philips, is a spokesperson for the launch, articulating the strategic importance of the iMR solution. His role is primarily communicative, with no direct financial impact.
Importance 20.0 Sentiment 0.0
per
Steve Wedan, Founder and CEO of Imricor, is a spokesperson for the launch, highlighting the collaborative vision and the significance of the iMR lab solution. His role is primarily communicative, with no direct financial impact.
Importance 20.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.